Active Ingredient: TOREMIFENE CITRATE
Proprietary Name: TOREMIFENE CITRATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 60MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A208813
Product Number: 001
Approval Date: Dec 4, 2018
Applicant Holder Full Name: RISING PHARMA HOLDINGS INC
Marketing Status:
Prescription
Patent and Exclusivity Information